BSE Live
Jul 01, 16:01Prev. Close
4399.90
Open Price
4370.05
Bid Price (Qty.)
4379.30 (10)
Offer Price (Qty.)
4384.35 (3)
NSE Live
Jul 01, 15:58Prev. Close
4393.80
Open Price
4385.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4385.90 (29)
Cash Flow of Dr Reddys Laboratories (in Rs. Cr.) | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 0.00 | 3,056.20 | 2,775.80 | 1,700.70 | 697.00 | |
Net CashFlow From Operating Activities | 0.00 | 3,514.20 | 1,839.20 | 2,762.10 | 1,538.60 | |
Net Cash Used In Investing Activities | 0.00 | -1,458.00 | -1,689.20 | -550.90 | -1,179.90 | |
Net Cash Used From Financing Activities | 0.00 | -794.30 | -224.10 | -2,223.10 | -304.40 | |
Foreign Exchange Gains / Losses | 0.00 | 4.40 | 0.00 | 4.40 | -0.30 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 0.00 | 1,266.30 | -74.10 | -7.50 | 54.00 | |
Cash And Cash Equivalents Begin of Year | 0.00 | 39.10 | 113.20 | 120.70 | 66.70 | |
Cash And Cash Equivalents End Of Year | 0.00 | 1,305.40 | 39.10 | 113.20 | 120.70 |
19.05.2022
Dr Reddys Labs Consolidated March 2022 Net Sales at Rs 5,474.90 crore, up 14.82% Y-o-Y
19.05.2022
Dr Reddys Labs Standalone March 2022 Net Sales at Rs 3,668.70 crore, up 9.49% Y-o-Y
19.05.2022
Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
01.02.2022
Dr Reddys Labs Consolidated December 2021 Net Sales at Rs 5,338.30 crore, up 8.02% Y-o-Y
28.01.2022
Dr Reddy’s Q3 Preview | Revenue expected to increase 10-15%, PAT likely to grow 22-25%
06.10.2021
Dr. Reddy’s Laboratories Q2 PAT may dip 11.5% YoY to Rs 752.2 cr: Prabhudas Lilladher
13.07.2021
Dr. Reddy’s Laboratories Q1 PAT seen up 10.2% YoY to Rs 655.4 cr: KRChoksey
12.07.2021
Dr Reddy’s Q1 PAT seen up 5.4% YoY to Rs 626.7 cr: ICICI Direct